慢性肾脏病贫血患者心血管安全性问题探析  

Cardiovascular safety in CKD patients with anemia

作　　者：贾媛媛[1] 金方霞 杜玄一[1] JIA Yuan-yuan;JIN Fang-xia;DU Xuan-yi(Department of Nephrology,The Second Affiliated Hospital of Harbin Medical University,Harbin 150086,China)

机构地区：[1]哈尔滨医科大学附属第二医院肾内科,哈尔滨150086

出　　处：《中国血液净化》2020年第6期364-367,共4页Chinese Journal of Blood Purification

摘　　要：贫血是慢性肾脏病(chronic kidney disease,CKD)最常见的并发症之一。心血管疾病(cardiovascular disease,CVD)是CKD 3~5期患者的首要致死原因。CKD贫血能够加重多系统器官的损伤,是CKD患者伴有心血管并发症的独立危险因素。因此,加强对CKD患者贫血的管理,有利于改善CKD患者的心血管结局。本文主要从CKD贫血本身以及治疗等方面对CKD贫血患者的心血管安全问题进行综述。Anemia is one of the most common complications in chronic kidney disease(CKD)patients.Cardiovascular disease is a major cause of mortality in CKD patients at stage 3~5.Renal anemia can aggravate the multisystem organ damages and is an important independent risk factor for cardiovascular complications in CKD patients.Therefore,management of renal anemia must be emphasized to improve the cardiovascular outcome in CKD patients.This article reviews cardiovascular safety in CKD patients with anemia from the view point of renal anemia and its treatment.

关 键 词：贫血 慢性肾脏病 心血管疾病 罗沙司他 

分 类 号：R453[医药卫生—治疗学]